Single Centre Study to Document Simplicity of Handling and Safety of Transcranial Laserneedle-Stimulation with the Weberneedle®-System in Subacute Ischemic Stroke in Daily Practice

The purpose of this non-interventional, exploratory trial is to document in 20 stroke patients the simplicity of handling and safety of transcranial laser needle stimulation with the Weberneedle®-System in the treatment of subacute ischemic stroke in daily routine practice. Treatment with laser needle stimulation is initiated within one week after onset of stroke; it will be applied once daily for 20 minutes for 5-10 days depending on the length of hospital stay of the patient. Safety and the neurological outcome (National Institutes of Health Stroke Scale (NIHSS), Rankin Scale, Bartel Index, Mini–Mental State Examination (MMSE)) will be observed over a period of 90 days.